VNRX institutional ownership changes in Q2 2026: 0 institutions opened or added positions, 20 trimmed or exited. VNRX (VOLITIONRX LTD) is held by 0 institutional investors as of Q2 2026. Top institutional shareholders: GEODE CAPITAL MANAGEMENT, LLC ($74,986), VANGUARD CAPITAL MANAGEMENT LLC ($68,423), Wealthspire Advisors, LLC ($60,750). Net institutional sentiment: Bearish.
Who's Trading
Source dates: Price Nov 2, 2026 · Insiders Oct 23, 2026 · Activists May 15, 2026 · Congress none
Top Holders
Showing 1-20 of 23
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about VNRX
Who owns VNRX?
0 institutional investors held VNRX on June 30, 2026, led by GEODE CAPITAL MANAGEMENT, LLC ($74,986), VANGUARD CAPITAL MANAGEMENT LLC ($68,423) and Wealthspire Advisors, LLC ($60,750).
How many hedge funds hold VNRX?
0 institutional investors reported VNRX in their 13F filings for the quarter ended June 30, 2026. One of them is rated Elite.
Are institutions buying or selling VNRX?
Selling, on balance. In Q2 2026, 20 institutions trimmed or exited VNRX and 0 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer